Skip to main content
Top
Published in: International Journal of Hematology 2/2019

01-02-2019 | Images in Hematology

Villous lymphocytes in splenic large B-cell lymphoma with diffuse red pulp infiltration

Authors: Ren-Ching Wang, L. Jeffrey Medeiros, Kung-Chao Chang

Published in: International Journal of Hematology | Issue 2/2019

Login to get access

Excerpt

A 66-year-old woman presented with fever, night sweats, and abdominal fullness for 2 months. A complete blood count showed pancytopenia with WBC 2520 /µL, Hb: 9.9 g/dL, and PLT: 78 × 103 /µL and 1% villous lymphocytes (panel A) in the blood smear. The serum LDH level was very high, 2340 IU/L. An abdominal computed tomography (CT) scan revealed a huge spleen (22 cm) with a few small mesenteric lymph nodes (< 1 cm, panel B). The resected spleen (1370 gm) had a homogenous cut surface. Microscopically, there was diffuse red pulp infiltration by medium-sized-to-large lymphocytes (panel C) shown by immunohistochemistry to be positive for CD20, CD79a (panel D), PAX5, Bcl-2, Bcl-6, and CD5 and with a Ki-67 index of 80% (panel E). The lymphocytes were negative for DBA.44, MNDA, CD10, IgD, CD23, LEF-1, cyclin D1, SOX11, CD25, CD123, Annexin A1, and BRAF-V600E. Although villous lymphocytes were observed, the high proliferative index supported a diagnosis of large B-cell lymphoma. The post-operative course was uneventful, and adjuvant chemotherapy was scheduled. The blood examination revealed no more villous lymphocytes. Unfortunately, neck, axillary, and inguinal lymphadenopathy developed 2 months after splenectomy. A follow-up positron emission tomography (PET)-CT showed additional para-aortic lymphadenopathy with high FDG uptake (panel F). Pathology confirmed infiltration of large cell lymphoma with the same immunophenotype. The lesion proved to be refractory, and the patient died in Aug. 2018, 9 months after diagnosis. …
Literature
1.
go back to reference Traverse-Glehen A, Baseggio L, Bauchu EC, Morel D, Gazzo S, Ffrench M, et al. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity? Blood. 2008;111(4):2253–60.CrossRefPubMed Traverse-Glehen A, Baseggio L, Bauchu EC, Morel D, Gazzo S, Ffrench M, et al. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity? Blood. 2008;111(4):2253–60.CrossRefPubMed
2.
go back to reference Mollejo M, Algara P, Mateo MS, Menarguez J, Pascual E, Fresno MF, et al. Large B-cell lymphoma presenting in the spleen: identification of different clinicopathologic conditions. Am J Surg Pathol. 2003;27(7):895–902.CrossRefPubMed Mollejo M, Algara P, Mateo MS, Menarguez J, Pascual E, Fresno MF, et al. Large B-cell lymphoma presenting in the spleen: identification of different clinicopathologic conditions. Am J Surg Pathol. 2003;27(7):895–902.CrossRefPubMed
Metadata
Title
Villous lymphocytes in splenic large B-cell lymphoma with diffuse red pulp infiltration
Authors
Ren-Ching Wang
L. Jeffrey Medeiros
Kung-Chao Chang
Publication date
01-02-2019
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2019
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-018-02566-x

Other articles of this Issue 2/2019

International Journal of Hematology 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine